Literature DB >> 20452738

Stereotaxy: breaking the limits of current radiofrequency ablation techniques.

Reto Bale1, Gerlig Widmann, D I Rudolf Stoffner.   

Abstract

Radiofrequency ablation (RFA) allows for local curative tumor treatment by inducing coagulation necrosis with high-frequency alternating current. However, the tumor size is the major limiting factor due to a mismatch of the tumor volume and the induced necrotic zone. RFA probes have to be optimally distributed in and around the tumor in order to produce overlapping ablation zones. Due to different guidance and ablation strategies the result is strongly operator dependent and there is a lack of reliability. These challenges can be managed by 3D-planning using a frameless stereotactic navigation system, allowing for the simultaneous display of multiple trajectories. The spatial information gained from 3D imaging is available in coordinates and thus forms an accurate input for performing the intervention. Stereotaxy enables highly accurate probe positioning. Stereotactic radiofrequency ablation (SRFA) may substantially improve the safety and efficacy in clinical practice, especially in the treatment of large and irregularly shaped tumors. The proposed methods may also be used for similar percutaneous local tumor treatments. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20452738     DOI: 10.1016/j.ejrad.2010.04.013

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  14 in total

1.  Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.

Authors:  Reto Bale; Gerlig Widmann; Peter Schullian; Marion Haidu; Georg Pall; Alexander Klaus; Helmut Weiss; Matthias Biebl; Raimund Margreiter
Journal:  Eur Radiol       Date:  2011-11-10       Impact factor: 5.315

2.  Computer planned, image-guided combined resection and ablation for bilobar colorectal liver metastases.

Authors:  Vanessa M Banz; Matthias Baechtold; Stefan Weber; Matthias Peterhans; Daniel Inderbitzin; Daniel Candinas
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Role of local ablative therapy for hepatocellular carcinoma.

Authors:  Ragesh B Thandassery; Usha Goenka; Mahesh K Goenka
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

4.  Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.

Authors:  Evelyne Bareck; Ahmed Ba-Ssalamah; Thomas Brodowicz; Wolfgang Eisterer; Michael Häfner; Christoph Högenauer; Ulrike Kastner; Thomas Kühr; Friedrich Längle; Bernadette Liegl-Atzwanger; Sebastian F Schoppmann; Gerlig Widmann; Fritz Wrba; Johannes Zacherl; Ferdinand Ploner
Journal:  Wien Med Wochenschr       Date:  2013-03-19

Review 5.  [Radiofrequency ablation of hepatocellular carcinoma].

Authors:  Gerlig Widmann; Peter Schullian; Reto Bale
Journal:  Wien Med Wochenschr       Date:  2013-03-21

6.  Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.

Authors:  Peter Schullian; Edward Johnston; Gregor Laimer; Daniel Putzer; Gernot Eberle; Yannick Scharrl; Claudia Ianetti-Hackl; Reto Bale
Journal:  Cardiovasc Intervent Radiol       Date:  2021-04-06       Impact factor: 2.740

Review 7.  Local Treatment of Breast Cancer Liver Metastasis.

Authors:  Reto Bale; Daniel Putzer; Peter Schullian
Journal:  Cancers (Basel)       Date:  2019-09-11       Impact factor: 6.639

8.  Stereotactic Radiofrequency Ablation of an Unresectable Intrahepatic Cholangiocarcinoma (ICC): Transforming an Aggressive Disease into a Chronic Condition.

Authors:  Gregor Laimer; Nikolai Jaschke; Maximilian Gottardis; Peter Schullian; Daniel Putzer; Wolfgang Sturm; Reto Bale
Journal:  Cardiovasc Intervent Radiol       Date:  2020-03-11       Impact factor: 2.740

9.  [Stereotaxy and robotics for ablation - toy or tool?].

Authors:  R Bale; G Widmann; W Jaschke
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

10.  Integrating interventional oncology in the treatment of liver tumors.

Authors:  D Putzer; P Schullian; E Braunwarth; M Fodor; F Primavesi; B Cardini; T Resch; R Oberhuber; M Maglione; C Margreiter; S Schneeberger; S Stättner; D Öfner-Velano; W Jaschke; R J Bale
Journal:  Eur Surg       Date:  2018-04-13       Impact factor: 0.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.